The reverse transport of DA, what physiological significance?

Neurochemistry International - Tập 38 Số 2 - Trang 83-106 - 2001
Vincent Leviel1
1Centre d'Etude et de Recherche Médicale par Emission de Positons (CERMEP), 59 Bd Pinel, 69008 Lyon, France

Tóm tắt

Từ khóa


Tài liệu tham khảo

Adam-Vizi, 1992, External Ca2+-independent release of neurotransmitters, J. Neurochem., 58, 395, 10.1111/j.1471-4159.1992.tb09736.x

Agid, 1973, Hyperactivity of remaining dopaminergic neurons after partial destruction of the nigrostriatal dopaminergic system in the rat, Nature, 245, 150

Agnati, 1986, A correlation analysis of the regional distribution of central enkephalin and beta endorphin immunoreactive terminals and of opiate receptors in adult and old male rats. Evidence for the existence of two main types of communication in the central nervous system: the volume transmission and the wiring transmission, Acta Physiol. Scand., 128, 201, 10.1111/j.1748-1716.1986.tb07967.x

Ahn, 1991, Biphasic striatal dopamine release during transcient ischemia and reperfusion in gerbils, Stroke, 22, 674, 10.1161/01.STR.22.5.674

Alexander, 1990, Functional architecture of basal ganglia circuits: neural substrates of parallel processing, Trends in Neurosci., 13, 266, 10.1016/0166-2236(90)90107-L

Altar, 1989, Preservation of dopamine release in the denervated striatum, Neurosci. Lett., 96, 329, 10.1016/0304-3940(89)90400-X

Amara, 1993, Neurotransmitter transporters: recent progress, Annu. Rev. Neurosci., 16, 73, 10.1146/annurev.ne.16.030193.000445

Arbuthnott, 1990, Dopamine release and metabolism in the rat striatum: an analysis by ‘in vivo’ brain microdyalisis, Pharmac. Ther., 48, 281, 10.1016/0163-7258(90)90050-C

Arluison, 1978, Dopaminergic nerve endings in the neostriatum of the rat. Part 1. Identification by intracerebral injections of 5-hydroxydopamine, Neuroscience, 3, 657, 10.1016/0306-4522(78)90063-5

Arluison, 1978, Dopaminergic nerve endings in the neostriatum of the rat. Part 2. Radioautographic study following local microinjections of tritiated dopamine, Neuroscience, 3, 675, 10.1016/0306-4522(78)90064-7

Arnold, 1977, The release of endogenous norepinephrine and dopamine from cerebral cortex by amphetamine, J. Pharm. Exp. Therap., 202, 544

Atwell, 1993, Nonvesicular release of neurotransmitter, Neuron, 11, 401, 10.1016/0896-6273(93)90145-H

Azzaro, 1974, The importance of neuronal uptake of amines for amphetamine-induced release of 3H-norepinephrine from isolated brain tissue, J. Pharm. Exp. Therap., 189, 110

Bach-Y-Rita, 1993, Neurotransmission in the brain by diffusion through the extracellular fluid: a review, NeuroReport, 4, 343, 10.1097/00001756-199304000-00001

Barber, 1976, Recurrent hormone-dependent chorea: effects of oestrogens and progesterone, Clin. Endocrinol., 5, 291, 10.1111/j.1365-2265.1976.tb01956.x

Barbour, 1997, Intersynaptic diffusion of neurotransmitter, Trends Neurosci., 20, 377

Bauman, 1976, Is drug inhibition of dopamine uptake a misinterpretation of in vitro experiments?, Nature, 264, 789, 10.1038/264789a0

Beaudet, 1978, The monoamine innervation of rat cerebral cortex: synaptic and non synaptic axon terminals, Neuroscience, 3, 851, 10.1016/0306-4522(78)90115-X

Benfenati, 1989, Transcient forebrain ischemia produces multiple deficitsin dopamine D1 transmission in the lateral neostriatum of the rat, Brain Res., 498, 376, 10.1016/0006-8993(89)91120-7

Benloucif, 1993, Serotonin-facilitated dopamine release in vivo: pharmacological characterization, J. Pharm. Exp. Therap., 265, 373

Benuck, 1992, Dopamine releasing effect of phenylbiguanide in rat striatal slices, Naunyn Schmiedeberg’s Arch. Pharmac., 345, 666, 10.1007/BF00164581

Berman, 1996, Modification of dopamine transporter function: effect of reactive oxygen species and dopamine, J. Neurochem., 67, 593, 10.1046/j.1471-4159.1996.67020593.x

Bernath, 1992, Calcium-independent release of amino acid neurotransmitters: fact or artifact, Prog. Neurobiol., 38, 57, 10.1016/0301-0082(92)90035-D

Besson, 1969, Release of newly synthesized dopamine from dopamine containing terminals in the striatum of the rat, Proc. Natl. Acad. Sci., 62, 741, 10.1073/pnas.62.3.741

Besson, 1973, In vivo continuous estimation of 3H-dopamine synthesis and release in the cat caudate nucleus, Naunyn Schmiedeberg’s Arch. Pharmacol., 278, 101, 10.1007/BF00501867

Besson, 1974, In vivo spontaneous and evoked release of newly synthesized dopamine in the cat caudate nucleus, Adv. Neurology, 5, 69

Björklund, 1975, Dopamine in dendrites of substantia nigra neurons: suggestions for a role in dendritic terminals, Brain Res., 83, 531, 10.1016/0006-8993(75)90849-5

Blanchard, 1993, Sex differences in ethanol-induced dopamine release in nucleus accumbens and in ethanol consumption in rats, Alcohol, 17, 968, 10.1111/j.1530-0277.1993.tb05650.x

Bogdanski, 1969, The effects of inorganic ions on the storage and uptake of [3H]norepinephrine by rat heart slices, J. Pharm. Exp. Ther., 165, 181

Boja, 1992, Expression of a single dopamine transporter cDNA can confer two cocaine binding sites, NeuroReport, 3, 247, 10.1097/00001756-199203000-00007

Boja, 1992, High-affinity binding of [125I]RTI-55 to dopamine and serotonin transporters in rat brain, Synapse, 12, 27, 10.1002/syn.890120104

Bonanno, 1987, Coexistence of carriers for dopamine and GABA uptake on a same nerve terminal in the rat brain, Br. J. Pharmacol., 91, 237, 10.1111/j.1476-5381.1987.tb09004.x

Bonhomme, 1995, Evidence for 5HT4 receptor subtype involvement in the enhancement of striatal dopamine release induced by serotonin: a microdialysis study in the halothane-anesthetized rat, Neuropharmacology, 34, 269, 10.1016/0028-3908(94)00145-I

Bonnet, 1984, Simultaneous evaluation by a double labelling method of drug-induced uptake inhibition and release of dopamine in synaptosomal preparation of rat striatum, Biochem. Pharmacol., 33, 2129, 10.1016/0006-2952(84)90583-5

Bönisch, 1983, Tetrodotoxin-sensitive and resistant effects of veratridine on the noradrenergic neurone of the rat vas deferens, Naumyn Schmiedeberg’s Arch. Pharmacol., 324, 264, 10.1007/BF00502621

Bönisch, 1986, The role of co-transported sodium in the effect of indirectly acting sympathomimetic amines, Naumyn Schmiedeberg’s Arch. Pharmacol., 332, 135, 10.1007/BF00511403

Brown, 1992, Alcohol inhibition of NMDA-stimulated catecholamine efflux in aging brain, Alcohol, 9, 555, 10.1016/0741-8329(92)90096-S

Bunney, 1973, Comparison of effects of l-dopa, amphetamine and apomorphine on firing rate of rat dopaminergic neurones, Nature, 245, 123

Butcher, 1988, Amphetamine induced dopamine release in the rat striatum: an in vivo microdialysis study, J. Neurochem., 50, 346, 10.1111/j.1471-4159.1988.tb02919.x

Buyukuysal, 1999, Anoxia-induced dopamine release from rat striatal slices: involvement of reverse transport mechanism, J. Neurochem., 72, 1507, 10.1046/j.1471-4159.1999.721507.x

Calligaro, 1988, High affinity stereospecific binding of [3H] cocaine in striatum and its relationship to the dopamine transporter, Membr. Biochem., 7, 87, 10.3109/09687688709039986

Carlsson, 1987, Early intraneuronal mobilization and deamination of noradrenaline during global ischemia in the isolated perfused rat heart, Naunyn Schmiedeberg’s Arch. Pharmacol., 336, 508, 10.1007/BF00169307

Castro, 1996, Increased neostriatal tyrosine hydroxylation during stress: role of extracellular dopamine and excitatory amino acids, J. Neurochem., 66, 824, 10.1046/j.1471-4159.1996.66020824.x

Cass, 1994, Direct in vivo evidence that D2 dopamine receptors can modulate dopamine uptake, Neurosci. Lett., 176, 259, 10.1016/0304-3940(94)90096-5

Cass, 1995, Increased dopamine clearence in the non lesioned striatum of rhesus monkeys with unilateral 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) striatal lesions, Neurosci. Lett., 185, 52, 10.1016/0304-3940(94)11223-6

Chan, 1995, Localisation of the vesicular monoamine transporter-2 in the dendrites of dopaminergic neurons: comparison of rat substantia nigra and ventral tegmental area, Soc. Neurosci. Abstr., 21, 373

Chéramy, 1981, Dendritic release of dopamine in the substantia nigra, Nature, 289, 537, 10.1038/289537a0

Chetty, 1992, The effects of cadmium in vitro on adenosine triphosphatase system and protection by thiol reagents in rat brain microsomes, Arch. Environ. Contam. Toxicol., 22, 456, 10.1007/BF00212567

Chien, 1990, Estimation of free dopamine in the cytoplasm of the giant dopamine cell of planorbis corneus by voltametry and capillary electrophoresis, J. Neurochem., 54, 633, 10.1111/j.1471-4159.1990.tb01918.x

Chiueh, 1975, d-amphetamine induced release of newly synthesized and stored dopamine from the caudate nucleus in vivo, J. Pharm. Exp. Therap., 192, 642

Chubb, 1972, Tyramine does not release noradrenaline from splenic nerves by exocytosis, Naunyn Schmiedeberg’s Arch. Pharmacol., 274, 281, 10.1007/BF00501937

Ciliax, 1994, Immunocytochemical localization of D1 and D2 receptors in rat brain, 383

Ciliax, 1995, The dopamine transporter: immunochemical characterization and localization in brain, J. Neurosci., 15, 1714, 10.1523/JNEUROSCI.15-03-01714.1995

Clow, 1989, Characterization of L-glutamate action on the release of endogenous dopamine from the rat caudate putamen, J. Pharm. Exp. Therap., 248, 722

Commissiong, 1990, Regulation of the synthesis and metabolism of striatal dopamine after disruption of nerve conduction in the medial forebrain bundle, Br. J. Pharmacol., 99, 741, 10.1111/j.1476-5381.1990.tb13000.x

Cooper, 1984, Possible mechanisms involved in the release and modulation of release of neuroactive agents, Neurochem. Int., 6, 419, 10.1016/0197-0186(84)90111-6

Cragg, 1997, Heterogeneity of electrically evoked dopamine release and reuptake in substantia nigra, ventral tegmental area, and striatum, J. Neurophysiol., 77, 863, 10.1152/jn.1997.77.2.863

Cragg, 1998, Dopamine is release spontaneously from developing midbrain neurons in organotypic culture, Neuroscience, 84, 325, 10.1016/S0306-4522(97)00657-X

Crespi, 1997, Carrier-dependent and Ca(2+)-dependent 5-HT and dopamine release induced by (+)amphetamine, 3,4-methylendioxymethamphetamine, p-chloroamphetamine and (+)-fenfluramine, Br. J. Pharmacol., 121, 1735, 10.1038/sj.bjp.0701325

Cuello, A.C., Iversen, L.L. 1978. In: Garattini, S., Pujol, J.F., Samanin, R., (Eds.) Interactions of Dopamine with Other Neurotransmitters in the Rat Substantia Nigra: a Possible Functional Role of Dendritic Dopamine. New York, pp. 127–149

Cuello, 1983, Nonclassical neuronal communications, Federation Proc., 42, 2912

Daoust, 1986, Striatal dopamine does not appear involved in the voluntary intake of ethanol by rats, Alcohol, 3, 15, 10.1016/0741-8329(86)90065-0

David, 1998, In vivo electrochemical studies of dopamine clearance in subregions of rat nucleus accumbens: differential properties of the core and shell, Exp. Neurol., 153, 277, 10.1006/exnr.1998.6898

Debler, 1988, Ascorbic acid and striatal transport of [3H]1-methyl-4-phenylpyridine (MPP+)and [3H]dopamine, Life Sci., 42, 2553, 10.1016/0024-3205(88)90323-2

Debler, 1991, Carrier mediated efflux of [3H]dopamine and [3H]1-methyl-4-phenylpyridine: effect of ascorbic acid, Synapse, 7, 99, 10.1002/syn.890070203

de Deurwaerdere, 1995, d-Fenfluramine increases striatal extracellular dopamine in vivo independently of serotoninergic terminals or dopamine or dopamine uptake sites, J. Neurochem., 65, 1100, 10.1046/j.1471-4159.1995.65031100.x

Del Castillo, 1956, Biophysical aspects of neuromuscular transmission, Prog. Biophys. Biophys. Chem., 6, 121, 10.1016/S0096-4174(18)30106-9

Descarries, 1975, Serotonin nerve terminals in adult rat neocortex, Brain Res., 100, 563, 10.1016/0006-8993(75)90158-4

Descarries, 1980, Dopaminergic nerve endings visualised by high resolution autoradiography in adult rat neostriatum, Nature, 284, 620, 10.1038/284620a0

Descarries, 1996, Dual character, asynaptic and synaptic, of the dopamine innervation in adult rat neostriatum: a quantitative autoradiographic and immunocytochemical anlysis, J. Comp. Neurol., 375, 167, 10.1002/(SICI)1096-9861(19961111)375:2<167::AID-CNE1>3.0.CO;2-0

Desce, 1992, L-glutamate evoked release of dopamine from synaptosomes of the rat striatum: involvement of AMPA and N-methyl-D-aspartate receptors, Neuroscience, 47, 333, 10.1016/0306-4522(92)90249-2

Desce, 1993, Opposite presynaptic regulations by glutamate through NMDA receptors of dopamine synthesis and release in rat striatal synaptosomes, Brain Res., 640, 205, 10.1016/0006-8993(94)91874-0

Dickinson, 1999, Dopamine D2 receptor deficient mice exhibit decreased dopamine transporter function but no changes in dopamine release in dorsal striatum, J. Neurochem., 72, 148, 10.1046/j.1471-4159.1999.0720148.x

di Giovanni, 1999, Selective blockade of serotonin-2C/2B receptors enhances mesolimbic and mesostriatal dopaminergic function: a combined in vivo electrophysiological and microdialysis study, Neuroscience, 91, 587, 10.1016/S0306-4522(98)00655-1

Diliberto, 1987, Ionic mechanism of dopaminergic and muscarinic auto and heteroreceptot activation in superfused striatal slices: role of extracellular chloride, J. Pharm. Exp. Therap., 240, 795

Diliberto, 1989, Effects of low extracellular chloride on dopamine release and the dopamine transporter, J. Pharm. Exp. Therap., 248, 644

Dismukes, 1977, New look at the aminergic nervous system, Nature, 269, 557, 10.1038/269557a0

Disshon, 1998, Inhibition of striatal dopamine transporter activity by 17β-estradiol, Eur. J. Pharm., 345, 207, 10.1016/S0014-2999(98)00008-9

Donnan, 1991, Distribution of catecholamine uptake sites in human brain as determined by quantitative [3H]mazindol autoradiography, J. Comp. Neurol., 304, 419, 10.1002/cne.903040307

Du, 1998, Protection of neuronal uptake-1 inhibitors in ischemic and anoxic hearts by norepinephrine-dependent and -independent mechanisms, J. Cardiovasc. Pharmacol., 32, 621, 10.1097/00005344-199810000-00015

Earl, 1998, Pharmacological characterization of dopamine overflow in the striatum of the normal and MPTP-treated common marmoset, studied in vivo using fast cyclic voltametry, nomifensine and sulpiride, J. Neurosci. Meth., 85, 201, 10.1016/S0165-0270(98)00134-4

Elghozi, 1983, Nomifensine antagonizes the ouabain-induced increase in dopamine metabolites in cerebrospinal fluid of the rat, Eur. J. Pharmacol., 90, 279, 10.1016/0014-2999(83)90250-9

Elverfors, 1991, Reserpine-insensitive dopamine release in the substantia nigra, Brain Res., 557, 5, 10.1016/0006-8993(91)90109-9

Erecinska, 1987, Ammonia induced release of neurotransmoitters from rat brain synaptosomes: differences between the effects on amines and amino acids, J. Neurochem., 49, 1258, 10.1111/j.1471-4159.1987.tb10018.x

Espino, 1995, Chronic effects of single intrastriatal injections of 6-hydroxydopamine or 1-methyl-4-phenylpyridinium studied by microdialysis in freely moving rats, Brain Res., 695, 151, 10.1016/0006-8993(95)00705-U

Fairbrother, 1990, In vivo mechanisms underlying dopamine release from rat nigrostriatal terminals. Part II: Studies using potassium and tyramine, J. Neurochem., 54, 1844, 10.1111/j.1471-4159.1990.tb04881.x

Ferger, 1999, Malonate-induced generation of reactive oxygen species in rat striatum depends on dopamine release but not on NMDA receptor activation, J. Neurochem., 73, 1329, 10.1046/j.1471-4159.1999.0731329.x

Fillenz, 1993, Short-term control of transmitter synthesis in central catecholaminergic neurones, Prog. Biophys. Molec. Biol., 60, 29, 10.1016/0079-6107(93)90011-8

Filloux, 1993, Pre and post synaptic neurotoxic effects of dopamine demonstrated by intrastriatal injection, Exp. Neurol., 119, 79, 10.1006/exnr.1993.1008

Fischer, 1976, Properties of dopamine efflux from rat striatal tissue caused by amphetamine and parahydroxyamphetamine, Proc. West. Pharmacol. Soc., 19, 179

Fischer, 1979, Chemical release of dopamine from striatal homogenate: evidence for an exchange diffusion model, J. Pharm. Exp. Therap., 208, 203

Fung, 1982, The importance of calcium in the amphetamine-induced stimulation of dopamine synthesis in mouse striata in vivo, J. Pharm. Exp. Therap., 223, 477

Fuxe, 1968, Histochemical studies on the effect of (+)-amphetamine, drugs of the imipramine group and tryptamine on central catecholamine and 5-hydroxytryptamine neurons after intraventricular injection of catecholamines and 5-hydroxytryptamine, Eur. J. Pharm., 1, 135, 10.1016/0014-2999(68)90169-6

Fuxe, 1991, Two principal modes of electrochemical communication in the brain: volume versus wiring transmission, vol. 1, 1

Garris, 1994, Efflux of dopamine from the synaptic cleft in the nucleus accumbens of the rat brain, J. Neurosci., 14, 6084, 10.1523/JNEUROSCI.14-10-06084.1994

Garris, 1997, Dopamine release and uptake rates both decrease in the partially denervated striatum in proportion to the loss of dopamine terminals, Brain Res., 753, 225, 10.1016/S0006-8993(97)00003-6

Geffen, 1976, Release of DA from dendrites in rat SN, Nature, 260, 258, 10.1038/260258a0

Gerhart, 1996, In vivo electrochemical studies of dopamine overflow and clearance in the striatum of normal and MPTP-treated rhesus monkeys, J. Neurochem., 66, 579, 10.1046/j.1471-4159.1996.66020579.x

Giorguieff, 1977, Presynaptic effect of L-glutamic acid on the release of dopamine in rat striatal slices, Neurosci. Lett., 6, 73, 10.1016/0304-3940(77)90068-4

Giros, 1993, Molecular characterization of the dopamine transporter, Trends Pharmac. Sci., 14, 43, 10.1016/0165-6147(93)90029-J

Giros, 1996, Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter, Nature, 379, 606, 10.1038/379606a0

Globus, 1988, Intra-ischemic extracellular release of dopamine and glutamate is associated with striatal vulnerability to ischemia, Neurosci. Lett., 91, 36, 10.1016/0304-3940(88)90245-5

Glowinski, 1965, Metabolism of [3H]norepinephrine in the rat brain, J. Neurochem., 12, 25, 10.1111/j.1471-4159.1965.tb10247.x

Glowinski, 1966, Regional studies of catecholamines in the rat brain. Part IV: effects of drugs on the disposition and metabolism of 3H-norepinephrine and 3H-dopamine, J. Pharm. Exp. Ther., 153, 30

Glowinski, 1975, Properties and functions of intraneuronal monoamine compartments in central aminergic neurons, 139

Gobert, 1992, GnRH-associated peptide (GAP) is present in the rat striatum and affects the synthesis and release of dopamine, J. Neurosci. Res., 31, 354, 10.1002/jnr.490310218

Gotow, 1991, Cytoplasmic architecture of the axon terminal: filamentous strands specifically associated with synaptic vesicles, Neuroscience, 40, 587, 10.1016/0306-4522(91)90143-C

Grace, 1991, Phasic versus tonic release and the modulation of dopamine system responsitivity: a hypothesis for etiology of schizophrenia, Neuroscience, 41, 1, 10.1016/0306-4522(91)90196-U

Gracz, 1995, [3H]WIN 35, 428 ([3H]CFT) binds to multiple charge-states of the solubilized dopamine transporter in primate striatum, J. Pharm. Exp. Therap., 273, 1224

Greenfield, 1985, The significance of dendritic release of transmitter and protein in the substantia nigra, Neurochem. Int., 7, 887, 10.1016/0197-0186(85)90136-6

Groppetti, 1977, Changes in specific activity of dopamine metabolites as evidence of a multiple compartmentation of dopamine in striatal neurons, J. Neurochem., 28, 193, 10.1111/j.1471-4159.1977.tb07726.x

Groves, 1975, Self inhibition by dopaminergic neurons, Science, 190, 522, 10.1126/science.242074

Groves, 1983, Dendro-dendritic synapses in substantia nigra: descriptions based on analysis of serial sections, Exp. Brain Res., 49, 209, 10.1007/BF00238581

Groves, 1983, A theory of the functional organization of the neostriatum and the neostriatal control of voluntary movement, Brain Res. Rev., 5, 109, 10.1016/0165-0173(83)90011-5

Haass, 1989, Neuropeptide Y differentiates between exocytotic and nonexocytotic noradrenaline release in guinea-pig heart, Naunyn Schmiedeberg’s Arch. Pharmacol., 340, 509, 10.1007/BF00260605

Hantraye, 1990, MPTP: mécanismes biologiques et limites d’un modèle expérimental de la maladie de Parkinson, Circul. et métab. du Cerveau., 7, 15

Hastings, 1996, Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections, Proc. Natl. Acad. Sci. USA, 93, 1956, 10.1073/pnas.93.5.1956

Häusser, 1995, Axonal initiation and active dendritic propagation of action potentials in substantia nigra neurons, Neuron, 15, 637, 10.1016/0896-6273(95)90152-3

Heeringa, 1995, Biochemistry of somatodendritic dopamine release in substantia nigra: an in vivo comparison with striatal dopamine release, J. Neurochem., 65, 192, 10.1046/j.1471-4159.1995.65010192.x

Hefti, 1980, Partial lesion of the dopamine nigrostriatal system in rat brain: biochemical characterization, Brain Res., 195, 123, 10.1016/0006-8993(80)90871-9

Henry, 1998, The vesicular monoamine transporter: from chromaffin granule to brain, Neurochem. Int., 32, 227, 10.1016/S0197-0186(97)00092-2

Herdon, 1985, Differences between the release of radiolabelled and endogenous dopamine from superfused rat brain slices: effects of depolarizing stimuli, amphetamine and synthesis inhibition, Brain Res., 348, 309, 10.1016/0006-8993(85)90450-0

Hersch, 1997, Subcellular localization and molecular topology of the dopamine transporter in the striatum and substantia nigra, J. Comp. Neurol., 388, 211, 10.1002/(SICI)1096-9861(19971117)388:2<211::AID-CNE3>3.0.CO;2-4

Hollerman, 1990, The effects of dopamine-depleting brain lesions on the electrophysiological activity of rat substantia nigra dopamine neurons, Brain Res., 533, 203, 10.1016/0006-8993(90)91341-D

Horn, 1973, Structure activity relationships for inhibition of catecholamine uptake into synaptosomes from NE and DA neurons in rat brain, Brit. J. Pharmacol., 47, 332, 10.1111/j.1476-5381.1973.tb08331.x

Hoyt, 1997, Mechanisms of dopamine induced cell death in cultured rat forebrain neurons: interactions with and differences from glutamate-induced cell death, Exp. Neurol., 143, 269, 10.1006/exnr.1996.6374

Hubbard, 1970, Mechanism of transmitter release, Prog. Biophys., 21, 33, 10.1016/0079-6107(70)90023-4

Hunt, 1974, Nomifensine: a new potent inhibitor of dopamine uptake into synaptosomes from rat brain corpus striatum, J. Pharm. Pharmacol., 26, 370, 10.1111/j.2042-7158.1974.tb09294.x

Hunt, 1979, Dopamine uptake inhibitors and releasing agents differentiated by the use of synaptosomes and field-stimulated brain slices in vitro, Biochem. Pharmacol., 28, 2011, 10.1016/0006-2952(79)90217-X

Hurd, 1989, In vivo neurochemical profile of dopamine uptake inhibitors and releasers in rat caudate-putamen, Eur. J. Pharmacol., 166, 251, 10.1016/0014-2999(89)90066-6

Hurd, 1989, Ca2+ dependence of the amphetamine nomifensine and Lu19005 effect on in vivo dopamine transmission, Eur. J. Pharmacol., 166, 261, 10.1016/0014-2999(89)90067-8

Hurd, 1989, Influence of a carrier transport process on the in vivo release and metabolism of dopamine: dependence on extracellulat Na+, Life Sci., 45, 283, 10.1016/0024-3205(89)90137-9

Ikeda, 1966, A kinetic study of bovine adrenal tyrosine hydroxylase, J. Biol. Chem., 241, 4452, 10.1016/S0021-9258(18)99741-3

Inoue, 1995, Effects of transcient forebrain ischemia on long term enhancement of dopamine release in rat striatal slices, Brain Res., 671, 95, 10.1016/0006-8993(94)01325-C

Iravani, 1996, Real-time effects of N-methyl-D-aspartic acid on dopamine release in slices of rat caudate putamen: a study using fast cyclic voltametry, J. Neurochem., 66, 1076, 10.1046/j.1471-4159.1996.66031076.x

Iwasaki, 1992, Increased plasma concentrations of aspartate, glutamate and glycine in Parkinson’s disease, Neurosci. Lett., 145, 175, 10.1016/0304-3940(92)90015-Y

Jacocks, 1992, Serotonin-stimulated release of [3H]dopamine via reversal of the dopamine transporter in rat striatum and nucleus accumbens: a comparison with release elicited by potassium, N-methyl-D-aspartic acid, glutamic acid and D-amphetamine, J. Pharm. Exp. Therap., 262, 356

Johnson, 1988, Accumulation of biological amines into chromaffin granules; a model for hormone and neurotransmitter transport, Physiol. Rev., 68, 232, 10.1152/physrev.1988.68.1.232

Kahn, 1995, Nitric oxyde modulates dopamine release during global temporary cerebral ischemia, Anesth. Analg., 80, 1116

Kalivas, 1991, A comparison of axonal and somatodendritic dopamine release using in vivo dialysis, J. Neurochem., 56, 961, 10.1111/j.1471-4159.1991.tb02015.x

Kamal, 1981, Presynaptic modulation of the release of dopamine from the rabbit caudate nucleus: differences between electrical stimulation, amphetamine and tyramine, J. Pharm. Exp. Therap., 216, 592

Kamal, 1983, Amphetamine inhibits the electrically evoked release of [3H]dopamine from slices of the rabbit caudate, J. Pharm. Exp. Therap., 227, 446

Kapatos, 1977, Dopamine biosynthesis from L-tyrosine and L-phenylalanine in rat brain synaptosomes: preferential use of newly accumulated precursors, J. Neurochem., 28, 1109, 10.1111/j.1471-4159.1977.tb10675.x

Kebabian, 1976, Dopamine sensitive adenylate cyclase occurs in a region of substantia nigra containing dopaminergic dendrites, Science, 193, 683, 10.1126/science.181842

Keefe, 1992, Extracellular dopamine in striatum: influence of nerve impulse activity in medial forebrain bundle and local glutamatergic input, Neuroscience, 47, 325, 10.1016/0306-4522(92)90248-Z

Keefe, 1993, In vivo regulation of extracellular dopamine in the neostriatum: influence of impulse activity and local excitatory amino acids, J. Neural. Trans., 91, 223, 10.1007/BF01245233

Kim, 1995, Ca2+-dependent and -independent mechanisms of ischaemia-evoked release of [3H]-dopamine from rat striatal slices, Clin. Exp. Pharmac. Physiol., 22, 301, 10.1111/j.1440-1681.1995.tb02003.x

Kitayama, 1994, Phorbolesters alters functions of the expressed dopamine transporter, Eur. J. Pharmacol., 268, 115, 10.1016/0922-4106(94)90180-5

Kogure, 1975, Catecholamines in experimental brain ischemia, Arch. Neurol., 32, 21, 10.1001/archneur.1975.00490430043005

Kopin, 1968, Selective release of newly synthesized norepinephrine from the cat spleen during sympathetic nerve stimulation, J. Pharm. Exp. Therap., 161, 271

Kuczenski, 1975, Effects of catecholamine releasing agents on synaptosomal dopamine biosynthesis: multiple pools of dopamine or multiple forms of tyrosine hydroxylase, Neuropharmacology, 14, 1, 10.1016/0028-3908(75)90060-X

Kuczenski, 1990, Apomorphine does not alter amphetamine induced dopamine release measured in striatal dialysates, J. Neurochem., 54, 1492, 10.1111/j.1471-4159.1990.tb01196.x

Kuhr, 1985, Amphetamine attenuates the stimulated release of dopamine in vivo, J. Pharm. Exp. Therap., 232, 388

Kula, 1991, Lack of increase in dopamine transporter binding or function in rat b rain tissue after treatment with blockers of neuronal uptake of dopamine, Neuropharmacology, 30, 89, 10.1016/0028-3908(91)90047-F

L’hirondel, 1995, Effects of arachidonic acid on dopamine synthesis, spontaneous release, and uptake in striatal synaptosomes from the rat, J. Neurochem., 64, 1406, 10.1046/j.1471-4159.1995.64031406.x

Langer, 1984, The amphetamine paradox in dopaminergic neurotransmission, Trends Pharmacol. Sci., 5, 387, 10.1016/0165-6147(84)90478-4

Lavyne, 1975, Brain H-3-catecholamine metabolism in experimental cerebral ischemia, Neurology, 25, 483, 10.1212/WNL.25.5.483

Levi, 1976, Diaminobutyric acid: a tool for dicriminating between carrier-mediated and non carrier-mediated release of GABA from synaptosomes, Neurochem. Res., 1, 581, 10.1007/BF00965600

Levi, 1993, Carrier-mediated release of neurotransmitters, Trends Neurosci., 16, 415, 10.1016/0166-2236(93)90010-J

Leviel, 1979, Role of the dendritic release of dopamine in the reciprocal control of the two nigrostriatal dopaminergic pathways, Nature, 280, 237, 10.1038/280236a0

Leviel, 1987, Involvement of intraterminal dopamine compartments in the amine release in the cat striatum, Neurosci. Lett., 76, 197, 10.1016/0304-3940(87)90715-4

Leviel, 1989, Direct observation of dopamine compartmentation in striatal nerve terminal by in vivo measurement of the specific activity of released dopamine, Brain Res., 499, 205, 10.1016/0006-8993(89)90768-3

Leviel, 1990, The glutamate-mediated release of dopamine in the rat striatum: further characterization of the dual excitatory-inhibitory function, Neuroscience, 39, 305, 10.1016/0306-4522(90)90269-A

Leviel, 1991, Specifically evoked release of newly synthesized or stored dopamine by different treatments, 407

Leviel, 1994, The role of calcium ions in dopamine synthesis and dopamine release, 403

Liang, 1982, Evidence for carrier-mediated efflux of dopamine from corpus striatum, Biochem. Pharmac., 31, 2479, 10.1016/0006-2952(82)90057-0

Lin, 1995, Dynamic analysis of ethanol effects on NMDA-evoked dopamine overflow in rat striatum, Brain Res., 696, 15, 10.1016/0006-8993(95)00688-M

Lin, 1998, Role of dopamine uptake in NMDA modulated K(+)-evoked dopamine overflow in rat striatum: an in vivo electrochemical study, Neurosci. Res., 31, 171, 10.1016/S0168-0102(98)00036-4

Llinas, 1984, Electrophysiology of pars compacta cells in the in vitro substantia nigra — a possible mechanism for dendritic release, Brain Res., 294, 127, 10.1016/0006-8993(84)91316-7

Llinas, 1988, The intrinsic electrophysiological properties of mammalian neurons: insight into central nervous function, Science, 242, 1654, 10.1126/science.3059497

Lonart, 1994, Inhibitory effects of nitric oxide on the uptake of [3H]dopamine and [3H]glutamate by striatal synaptosomes, J. Neurochem., 63, 2108, 10.1046/j.1471-4159.1994.63062108.x

Lonart, 1990, N-Methyl-D-aspartate evokes dopamine release from rat striatum via dopamine uptake system, Soc. Neurosci. Abs., 16, 552

Lonart, 1991, High glutamate concentrations evoke Ca++ independent dopamine release from striatal slices, a possible role of reverse dopamine transport, J. Pharm. Exp. Therap., 256, 1132

Lucas, 2000, The effect of serotoninergic agents on haloperidol-induced striatal dopamine release in vivo: opposite role of 5-HT(2A) and 5-HT(2C) receptor subtypes and significance of the haloperidol dose used, Neuropharmacology, 39, 1053, 10.1016/S0028-3908(99)00193-8

Luthman, 1993, In vivo electrochemical measurements of exogenous dopamine clearance in normal and neonatal 6-hydroxydopamine treated rat striatum, Exp. Neurol., 122, 273, 10.1006/exnr.1993.1127

Lynch, 1983, Possible association of alcohol tolerance with increased synaptic Ca2+ sensitivity, Nature, 303, 175, 10.1038/303175a0

Maker, 1986, Amine mediated toxicity. The effects of dopamine, norepinephrine, 5-hydroxytryptamine, 6-hydroxydopamine, ascorbate, glutathione and peroxide on the in vivo activities of creatine and adenylate kinases in the brain of the rat, Neuropharmacology, 25, 25, 10.1016/0028-3908(86)90054-7

Maley, 1990, Monoamine synaptic structure and localization in the central nervous system, J. Electr. Microsc. Tech., 15, 20, 10.1002/jemt.1060150104

Maloteaux, 1988, [3H]GBR12935 binding to dopamine uptake sites: subcellular localization and reduction in parkinson’s disease and prograssive supranuclear palsy, Eur. J. Pharmacol., 156, 331, 10.1016/0014-2999(88)90278-6

Marie, 1992, Alpha-methyl-para-tyrosine pretreatment protect from striatal neuronal death induced by four-vessel occlusion in the rat, Neurochem. Res., 17, 961, 10.1007/BF00966821

Matsumoto, 1999, Characterization of endogenous serotonin-mediated regulation of dopamine release in the rat prefrontal cortex, Eur. J. Pharmacol., 383, 39, 10.1016/S0014-2999(99)00636-6

Maurin, 1999, Three dimensional distribution of nigrostriatal neurons in the rat: relation to the topography of striatonigral projections, Neuroscience, 91, 891, 10.1016/S0306-4522(98)00681-2

Maus, 1990, In vitro effects of 17 β-oestradiol on the sensitivity of receptors coupled to adenylate cyclase on striatal neurons in primary culture, 145

May, 1989, Effects of D2 antagonists on frequency dependent stimulated dopamine overflow in nucleus accumbens and caudate putamen, J. Neurochem., 53, 898, 10.1111/j.1471-4159.1989.tb11789.x

McMahon, 1989, Glutamate release from guinea-pig synaptosomes: stimulation by reuptake-induced depolarization, J. Neurochem., 53, 71, 10.1111/j.1471-4159.1989.tb07296.x

McMillen, 1980, Functional and pharmacological significance of brain dopamine and norepinephrine storage pools, Biochem. Pharmacol., 29, 3045, 10.1016/0006-2952(80)90444-X

Meiergerd, 1993, D2 receptors may modulate the function of the striatal transporter for dopamine kinetic evidence from studies in vitro and in vivo, J. Neurochem., 61, 764, 10.1111/j.1471-4159.1993.tb02185.x

Mennicken, 1992, Autoradiographic localization of dopamine uptake sites in the rat brain with [3H]-GBR12935, J. Neural. Trans., 87, 1, 10.1007/BF01253106

Meshul, 1999, Time dependent changes in striatal glutamate synapses following a 6-hydroxydopamine lesion, Neuroscience, 88, 1, 10.1016/S0306-4522(98)00189-4

Michael, 1987, Mechanisms contributing to the recovery of striatal releasable dopamine following MFB stimulation, Brain Res., 421, 325, 10.1016/0006-8993(87)91302-3

Miller, 1980, In vivo monoamine oxydase inhibition by d-amphetamine, Biochem. Pharmacol., 29, 1347, 10.1016/0006-2952(80)90429-3

Miller, 1982, Effects of amphetamine and amfonelic acid on the disposition of striatal newly synthesyzed dopamine, Eur. J. Parmacol., 78, 33, 10.1016/0014-2999(82)90369-7

Milusheva, 1992, Regulatory interactions among axon terminal affecting the release of different transmitters from rat striatal slices under hypoxic and hypoglycemic conditions, J. Neurochem., 59, 946, 10.1111/j.1471-4159.1992.tb08335.x

Milusheva, 1996, Effect of hypoxia and glucose deprivation on ATP level, adenylate energy charge and [Ca2+]-dependent and independent release of [3H]dopamine in rat striatal slices, Neurochem. Int., 28, 501, 10.1016/0197-0186(95)00129-8

Mirenowicz, 1996, Preferential activation of midbrain dopamine neurons by appetitive rather than aversive stimuli, Nature, 379, 449, 10.1038/379449a0

Moghadam, 1990, Effect of L-glutamate on the release of striatal dopamine: in vivo dialysis and electrochemical studies, Brain Res., 518, 55, 10.1016/0006-8993(90)90953-9

Nagatsu, 1964, Tyrosine hydroxylase: the initial step in norepinephrine biosynthesis, J. Biol. Chem., 239, 2910, 10.1016/S0021-9258(18)93832-9

Nash, 1991, Microdialysis studies on 3,4-methylenedioxymethamphetamine induced dopamine release: effect of dopamine uptake inhibitors, J. Pharm. Exp. Therap., 259, 820

Nemeth, 1991, Changes in striatal dopamine neurohistochemistry and biochemistry after incomplete transcient cerebral ischemia in the rat, Exp. Brain Res., 86, 545, 10.1007/BF00230527

Nicolaysen, 1988, Effects of cocaine on release and uptake of dopamine in vivo: differentiation by mathematical modeling, Pharmacol. Biochem. and Behav., 31, 327, 10.1016/0091-3057(88)90354-1

Niddam, 1985, Amphetamine induced release of endogenous dopamine in vitro is not reduced following pretreatment with reserpine, Naumyn Schmiedeberg’s Arch. Pharmacol., 329, 123, 10.1007/BF00501200

Nieoullon, 1977, Release of DA in vivo from cat SN, Nature, 266, 375, 10.1038/266375a0

Nirenberg, 1996, The dopamine transporter is localized to dendritic and axonal plasma membranes of nigrostriatal dopaminergic neurons, J. Neurosci., 16, 436, 10.1523/JNEUROSCI.16-02-00436.1996

Nissbrandt, 1985, Evidence for DA release and metabolism beyond the control of nerve impulses and DA receptors in rat substantia nigra, J. Pharm. Pharmacol., 37, 884, 10.1111/j.2042-7158.1985.tb04994.x

Ng, 1999, Regulation of striatal dopamine release through 5-HT1 and 5-HT2 receptors, J. Neurosci. Res., 55, 600, 10.1002/(SICI)1097-4547(19990301)55:5<600::AID-JNR7>3.0.CO;2-#

Nowycky, 1978, Dopaminergic neurons: role of presynaptic receptors in the regulation of transmitter biosynthesis, Prog. Neuro-Psychopharmac., 2, 139, 10.1016/0364-7722(78)90061-9

Nurse, 1988, Characterization of the effects of serotonin on the release of [3H]dopamine from rat nucleus accumbens and striatal slices, Neurochem. Res., 13, 403, 10.1007/BF01268873

Oh, 1998, Enhanced tyrosine phosphorylation of striatal NMDA receptor subunits: effect of dopaminergic denervation and L-DOPA administration, Brain Res., 813, 150, 10.1016/S0006-8993(98)01049-X

Okada, 1990, The Na+ d ependent release of endogenous dopamine and noradranaline from rat brain synaptosomes, J. Pharm. Exp. Therap., 252, 1283

Olefirowicz, 1990, Dopamine concentration in the cytoplasmic compartment of single neurons determined by capillary electrophoresis, J. Neurosci. Methods, 34, 11, 10.1016/0165-0270(90)90036-F

Olivier, 1995, Direct in vivo comparison of two mechanisms releasing dopamine in the rat striatum, Brain Res., 695, 1, 10.1016/0006-8993(95)00706-V

Olivier, 1999, The in vivo modulation of dopamine synthesis by calcium ions: influences on the calcium independent release, Neurochem. Int., 35, 431, 10.1016/S0197-0186(99)00094-7

Ooboshi, 1992, Inhibition of ischemia-induced dopamine release by omega-conotoxin, a calcium channel blocker, in the striatum of spontaneously hypertensive rats: in vivo brain dialysis study, J. Neurochem., 58, 298, 10.1111/j.1471-4159.1992.tb09310.x

Parsons, 1993, Co-administration of the D2 antagonist pimozide inhibits up-regulation of dopamine release and uptake induced by repeated cocaine, J. Neurochem., 60, 376, 10.1111/j.1471-4159.1993.tb05864.x

Parker, 1986, Effects of d-amphetamine and dopamine synthesis inhibitors on dopamine and acetylcholine neurotransmission in the striatum. I Release in the absence of vesicular transmitter stores, J. Pharm. Exp. Therap., 237, 179

Parker, 1986, Effects of d-amphetamine and dopamine synthesis inhibitors on dopamine and acetylcholine neurotransmission in the striatum. II Release in the presence of vesicular transmitter stores, J. Pharm. Exp. Therap., 237, 193

Parker, 1988, Comparative effects of amphetamine, phenylethylamine and related drugs on dopamine efflux, dopamine uptake and mazindol binding, J. Pharm. Exp. Therap., 245, 199

Pasqualini, 1993, Short-term inhibitory effect of estradiol on tyrosine hydroxylase activity in tuberoinfundibular dopaminergic neurons in vitro, J. Neurochem., 60, 1707, 10.1111/j.1471-4159.1993.tb13394.x

Pasqualini, 1994, Evidence for protein kinase C involvement in the short term activation by prolactin of tyrosine hydroxylase in tuberoinfundibular dopaminergic neurons, J. Neurochem., 62, 967, 10.1046/j.1471-4159.1994.62030967.x

Pasqualini, 1995, Acute stimulatory effect of estradiol on striatal dopamine synthesis, J. Neurochem., 65, 1651, 10.1046/j.1471-4159.1995.65041651.x

Pastuszko, 1982, Neurotransmitter metabolism in rat brain synaptosomes: effect of anoxia and pH, J. Neurochem., 38, 1657, 10.1111/j.1471-4159.1982.tb06647.x

Paton, 1973, Evidence for a carrier-mediated efflux of noradrenaline from the axoplasm of adrenergic nerves in rabbit atria, J. Pharm. Pharmac., 25, 265, 10.1111/j.2042-7158.1973.tb10639.x

Paton, 1973, Mechanism of efflux of noradrenaline from adrenergic nerves in rabbit atria, Br. J. Pharm., 49, 614, 10.1111/j.1476-5381.1973.tb08537.x

Philips, 1983, In vivo release of endogenous dopamine from rat caudate nucleus by phenylethylamine, Neuropharmacology, 22, 1297, 10.1016/0028-3908(83)90203-4

Phillipson, 1976, Substantia nigra of the rat contains a dopamine sensitive adenylate-cyclase, Nature, 261, 418, 10.1038/261418a0

Pickel, 1977, Regional and ultrastructural localization of tyrosine hydroxylase by immunocytochemistry, 321

Pickel, 1981, Ultrastructural immunocytochemical localization of tyrosine hydroxylase in the neostriatum, Brain Res., 225, 373, 10.1016/0006-8993(81)90843-X

Pogun, 1994, Nitric oxide inhibits [3H]dopamine uptake, Brain Res., 641, 83, 10.1016/0006-8993(94)91818-X

Premont, 1976, Is the dopamine sensitive adenylate cyclase in the rat substantia nigra coupled with autoreceptors?, Fed. Eur. Biochem. Soc. Lett., 68, 99, 10.1016/0014-5793(76)80414-0

Pulsinelli, 1985, Selective neuronal vulnerability: morphological and molecular characteristics, Prog. Brain Res., 63, 29, 10.1016/S0079-6123(08)61973-1

Raiteri, 1977, Effects of desmethyl imipramine on the release of [3H]norepinephrine induced by various agents in hypothalamic synaptosomes, Mol. Pharmacol., 13, 746

Raiteri, 1978, Release mechanism for catecholamine and serotonine in synaptosomes, 77

Raiteri, 1979, Dopamine can be release by two mechanisms differentially affected by the dopamine transport inhibitor nomifensine, J. Pharm. Exp. Therap., 208, 195

Rajanna, 1990, Effects of cadmium and mercury on Na+–K+ ATPase and uptake of 3H-dopamine in rat brain synaptosomes, Arch. Int. Physiol. Biochem., 98, 291, 10.3109/13813459009113989

Ramirez, 1985, Progesterone action on the LHRH and the nigrostriatal dopamine neuronal systems: in vitro and in vivo studies, Recent Prog. Horm. Res., 41, 421

Remblier, 1998, Extracellular dopamine and catabolite in rat striatum during lactic acid perfusion as determined by in vivo microdialysis, Brain Res., 804, 224, 10.1016/S0006-8993(98)00695-7

Remblier, 1999, Lactic acid-induced increase of extracellular dopamine measured by microdialysis in rat striatum: evidence for glutamatergic and oxydative mechanisms, Brain Res., 837, 22, 10.1016/S0006-8993(99)01699-6

Remblier, 1999, Origin of extracellular increase induced by lactic acid striatal perfusion monitored by microdialysis in the awake rat, NeuroReport, 10, 1961, 10.1097/00001756-199906230-00031

Rice, 1997, Characteristics of electrically evoked somatodendritic dopamine release in substantia nigra and ventral tegmental area in vitro, J. Neurophysiol., 77, 853, 10.1152/jn.1997.77.2.853

Richard, 1995, NMDA receptor blockade increases in vivo striatal dopamine synthesis and release in rats and mice with incomplete, dopamine depleting, nigrostriatal lesions, J. Neurochem., 64, 2080, 10.1046/j.1471-4159.1995.64052080.x

Richter, 1995, Dopamine transporter-dependent and independent endogenous dopamine release from weaver mouse striatum in vitro, J. Neurochem., 64, 191, 10.1046/j.1471-4159.1995.64010191.x

Roberts, 1978, Effects of L-glutamate and related amino acids upon the release of [3H]dopamine from rat striatal slices, Brain Res., 157, 391, 10.1016/0006-8993(78)90048-3

Roberts, 1979, Amphetamine and phenylethylamine-induced alterations in dopamine synthesis regulation in rat brain striatal synaptosomes, J. Pharm. Exp. Therap., 209, 104

Roberts, 1979, Stimulatory effect of L-glutamate and related amino acids on [3H]dopamine release from rat striatum: an in vitro model for glutamic actions, J. Neurochem., 32, 1539, 10.1111/j.1471-4159.1979.tb11096.x

Robinson, 1988, Normalization of extracellular dopamine in striatum following recovery from a partial unilateral 6-OHDA lesion of the substantia nigra: a microdialysis study in freely moving rats, Brain Res., 450, 209, 10.1016/0006-8993(88)91560-0

Roffler-Tarlov, 1990, Patterns of cell and fiber vulnerability in the mesostriatal system of the mutant mouse weaver. II. High affinity uptake, sites for dopamine, J. Neurosci., 10, 734, 10.1523/JNEUROSCI.10-03-00734.1990

Ross, 1964, Blocking action of sympathomimetic amines on the uptake of NE by mouse cerebral cortex, Acta Pharmacol. Toxicol., 31, 226, 10.1111/j.1600-0773.1964.tb01787.x

Ross, 1966, Uptake of some tritiated sympathomimetic amines by mouse brain cortex slices in vitro, Acta Pharmacol. Toxicol., 24, 297, 10.1111/j.1600-0773.1966.tb00392.x

Roth, 1976, Central dopaminergic neurons: effects of alterations in impulse flow on the accumulation of dihydroxyphenylacetic acid, Eur. J. Pharmacol., 36, 163, 10.1016/0014-2999(76)90268-5

Rudnick, 1992, The molecular mechanism of ‘ectasy’ [3,4-methylenedioxymethamphetamine (MDMA)]: serotonine transporters are targets for MDMA induced serotonin release, Proc. Natl. Acad. Sci., USA, 89, 1817, 10.1073/pnas.89.5.1817

Ruffieux, 1980, Dopaminergic activation of reticulata neurons in the substantia nigra, Nature, 285, 240, 10.1038/285240a0

Rutledge, 1970, The mechanism by which amphetamine inhibits oxydative deamination of norepinephrine in brain, J. Pharm. Exp. Therap., 171, 188

Samuel, 1990, Localization of N-methyl-D-aspartate receptors in the rat striatum: effects of specific lesions on the [3H]3-(2-carboxypiperazin-4)propyl-1-phosphonic acid binding, J. Neurochem., 54, 1926, 10.1111/j.1471-4159.1990.tb04893.x

Santiago, 1991, Characterization and pharmacological reponsivness of dopamine release recorded by microdialysis in the substantia nigra of conscious rats, J. Neurochem., 57, 738, 10.1111/j.1471-4159.1991.tb08214.x

Santos, 1996, Relationships between ATP depletion, membrane potential, and the release of neurotransmitters in rat nerve terminals. An in vitro study under conditions that mimic anoxia, hypoglycemia, and ischemia, Stroke, 27, 941, 10.1161/01.STR.27.5.941

Sarre, 1992, Biotransformation of L-DOPA in striatum and substantia nigra of rats with a unilateral, nigrostriatal lesion: a microdialysis study, Naumyn Schmiedeberg Arch. Pharmacol., 346, 277, 10.1007/BF00173540

Schacht, 1977, Studies on brain metabolism of biogenic amines, Br. J. Clin. Pharmacol., 4, 77S, 10.1111/j.1365-2125.1977.tb05763.x

Schmidt, 1989, The putative 5HT3 agonist phenylbiguanide induces carrier-mediated release of [3H]dopamine, Eur. J. Pharmac., 167, 309, 10.1016/0014-2999(89)90595-5

Schoemaker, 1983, Dopamine uptake by rat striatal synaptosomes: a compartmental analysis, J. Neurochem., 41, 684, 10.1111/j.1471-4159.1983.tb04795.x

Schömig, 1984, Release of endogenous catecholamines in the ischemic myocardium of the rat. Part A: locally mediated release, Circ. Res., 55, 689, 10.1161/01.RES.55.5.689

Schömig, 1987, Nonexocytotic release of endogenous noradrenaline in the ischemic and anoxic rat heart: mechanisms and metabolic requirements, Circ. Res., 60, 194, 10.1161/01.RES.60.2.194

Schömig, 1988, Neuronal sodium homeostasis and axoplasmic amine concentration determine calcium-independent noradrenaline release in normoxic and ischemic rat heart, Circ. Res., 63, 214, 10.1161/01.RES.63.1.214

Schuldiner, 1993, Amphetamine derivatives interact with both plasma membrane and secretory vesicle biogenic amine transporters, Mol. Pharmac., 44, 1227

Schultz, 1986, Response of midbrain dopamine neurons to behavioral trigger stimuli in the monkey, J. Neurophysiol., 56, 1439, 10.1152/jn.1986.56.5.1439

Schwartz, 1980, The relationship between the stimulation of dopamine synthesis and release produced by amphetamine and high potassium in striatal slices, J. Neurochem., 35, 1120, 10.1111/j.1471-4159.1980.tb07867.x

Sedvall, 1968, The rate of norepinephrine synthesis measured in vivo during short intervals: influence of adrenergic nerve impulse activity, J. Pharm. Exp. Therap., 159, 274

Sershen, 1987, Effect of ascorbic acid on the synaptosomal uptake of [3H]MPP+, [3H]dopamine, and [3H]GABA, J. Neurosci. Res., 17, 298, 10.1002/jnr.490170315

Shimada, 1991, Cloning and expression of a cocaine sensitive dopamine transporter complementary DNA, Science, 254, 576, 10.1126/science.1948034

Sill, 1999, Acute fluoxetine treatment potentiates amphetamine hyperactivity and amphetamine-induced nucleus accumbens dopamine release: possible pharmacokinetic interaction, Psychopharmacology, 141, 421, 10.1007/s002130050852

Simon, 1991, In vitro release of endogenous dopamine from the striatum of the Weaver mutant mouse, J. Neurochem., 57, 1478, 10.1111/j.1471-4159.1991.tb06341.x

Sirinathsinghji, 1988, In vivo studies on the dopamine reuptake mechanism in the striatum of the rat: effects of benztropine, sodium and ouabain, Brain Res., 438, 399, 10.1016/0006-8993(88)91372-8

Smolen, 1984, Effects of ethanol and salsolinol on catecholamine function in LS and SS mice, Pharmacol. Biochem. Behav., 20, 125, 10.1016/0091-3057(84)90112-6

Snape, 1988, Ethanol enhances the calcium-dependent stimulus induced release of endogeneous dopamine from slices of rat striatum and nucleus accumbens in vitro, Neuropharmacology., 27, 1097, 10.1016/0028-3908(88)90003-2

Snyder, 1990, Dopamine efflux from striatal slices after intracerebral 6-hydroxydopamine: evidence for compensatory hyperactivity of residual terminals, J. Pharm. Exp. Therap., 253, 867

Soares da Silva, 1990, Overflow of endogenous dopamine and 34 dihydroxyphenylacetic acid from tissues of the rat brain, elicited by electrical stimulation, depolarization by potassium ans activation of carrier-mediated release, Neuropharmacology, 29, 1151, 10.1016/0028-3908(90)90039-T

Sotelo, 1971, The fine structural localization of norepinephrine-3H in the substantia nigra and area postrema of the rat: an autoradiographic study, J. Ultrastruc. Res., 36, 824, 10.1016/S0022-5320(71)90033-5

Spatz, 1995, Modulation of striatal dopamine release in cerebral ischemia by L-arginine, Neurochem. Res., 20, 491, 10.1007/BF00973106

Stachowiak, 1987, Increased dopamine efflux from striatal slices during development and after nigrostriatal bundle damage, J. Neuroscience, 7, 1648, 10.1523/JNEUROSCI.07-06-01648.1987

Stamford, 1984, Striatal dopamine uptake in the rat: in vivo analysis by fast cyclic voltametry, Neurosci. Lett., 51, 133, 10.1016/0304-3940(84)90274-X

Stamford, 1999, Ascorbic acid is neuroprotective against global ischemia in striatum but not hippocampus: histological and voltametric data, Brain Res., 835, 229, 10.1016/S0006-8993(99)01587-5

Standaert, 1996, Inhibition of N-methyl-D-aspartate glutamate receptor subunit expression by antisens oliginucleotids reveals their role in striatal motor regulation, J. Pharm. Exp. Therap., 276, 342

Stein, 1967, 177

Stein, 1990

Stuart, 1994, Active propagation of somatic potentials into neocortical pyramidal cell dendrites, Nature, 367, 69, 10.1038/367069a0

Stute, 1984, The outward transport of axoplasmic noradrenaline induced by a rise of the sodium concentration in the adrenergic nerve endings of the rat vas deferens, Naunyn Schmiedeberg’s Arch. Pharmacol., 327, 124, 10.1007/BF00500906

Suaud-Chagny, 1995, Uptake of dopamine released by impulse flow in the rat mesolimbic and striatal systems in vivo, J. Neurochem., 65, 2603, 10.1046/j.1471-4159.1995.65062603.x

Sulzer, 1990, Amphetamine and other psychostimulants reduce pH gradients in midbrain dopaminergic neurons and chromaffin granules: a mechanism of action, Neuron, 5, 797, 10.1016/0896-6273(90)90339-H

Sulzer, 1993, Amphetamine and other weak bases act to promote reverse transport of dopamine in ventral midbrain neurons, J. Neurochem., 60, 527, 10.1111/j.1471-4159.1993.tb03181.x

Sulzer, 1995, Amphetamine redistributes dopamine from synaptic vesicles to the cytosol and promotes reverse transport, J. Neurosci., 15, 4102, 10.1523/JNEUROSCI.15-05-04102.1995

Sweadner, 1985, Ouabain evoked norepinephrine release from intact rat sympathetic neurons: evidence of carrier mediated release, J. Neurosci., 5, 2397, 10.1523/JNEUROSCI.05-09-02397.1985

Tauc, 1982, Nonvesicular release of neurotransmitter, Physiol. Rev., 62, 857, 10.1152/physrev.1982.62.3.857

Tennyson, 1974, 5-hydroxydopamine “tagged” neuronal boutons in rabbit neostriatum: interrelationship between vesicles and axonal membrane, Brain Res., 82, 341, 10.1016/0006-8993(74)90617-9

Thoenen, 1969, Cation dependence of the noradrenaline releasing action of tyramine, Eur. J. Pharmacol., 6, 29, 10.1016/0014-2999(69)90061-2

Toner, 1999, Effects of metabolic alterations on dopamine release in an in vitro model of neostriatal ischaemia, Brain Res. Bull., 48, 395, 10.1016/S0361-9230(99)00016-7

Udenfriend, 1965, Inhibitors of purified beef adrenal tyrosine hydroxylase, Biochem. Pharmacol., 14, 837, 10.1016/0006-2952(65)90103-6

Ulas, 1996, Dopaminergic denervation of striatum results in elevated expression of NR2A subunit, NeuroReport, 7, 1789, 10.1097/00001756-199607290-00020

Uretsky, 1977, Studies on the mechanism of stimulation of dopamine synthesis by amphetamine in striatal slices, J. Pharm. Exp. Therap., 202, 565

Uretsky, 1979, Effects of divalent cations on amphetamine induced stimulation of [3H]catechol synthesis in the striatum, J. Neurochem., 32, 951, 10.1111/j.1471-4159.1979.tb04580.x

Uvnas, 1984, Cation exchange — a common mechanism in the storage and release of biogenic amines stored in granules (vesicles), Acta Physiol. Scand., 120, 99, 10.1111/j.1748-1716.1984.tb07378.x

Vizi, 1980, Nonsynaptic modulation of transmitter release: pharmacological implications, TIPS, 2, 172

Vizi, 1984

Vizi, 1998, Different temperature dependence of carrier-mediated (cytoplasmic) and stimulus-evoked (exocytotic) release of transmitter: a simple method to separate the two types of release, Neurochem. Int., 33, 359, 10.1016/S0197-0186(98)00040-0

Vizi, 2000, Role of high-affinity receptors and membrane transporters in non synaptic communication and drug action in the central nervous system, Pharmacol. Rev., 52, 63

Vizi, 1986, Transmitter release from the cytoplasm is of physiological importance but no subject to presynaptic modulation, J. Physiol., Paris, 81, 283

Vizi, 1998, Neurochemistry and pharmacology of the major hippocampal transmitter systems: synaptic and non-synaptic interactions, Hippocampus, 8, 566, 10.1002/(SICI)1098-1063(1998)8:6<566::AID-HIPO2>3.0.CO;2-W

Vizi, 1991, Nonsynaptic interactions at presynaptic level, Prog. Neurobiol., 37, 145, 10.1016/0301-0082(91)90025-V

Walker, 1987, The synaptic vesicle and the cytoskeleton, Biochem. J., 247, 249, 10.1042/bj2470249

Wang, 1994, Restoration of dopamine overflow and clearance from the 6-hydroxydopamine lesioned rat striatum reinnervated by fetal mesencephalic grafts, J. Pharm. Exp. Therap., 270, 814

Wang, 1997, Effects of ethanol on striatal dopamine overflow and clearance: an in vivo electrochemical study, Alcohol, 14, 593, 10.1016/S0741-8329(97)00054-2

Wassef, 1981, Dopaminergic dendrites in the pars reticulata of the rat substantia nigra and their striatal input. Combined immunocytochemical localization of tyrosine hydroxylase and anterograde degeneration, Neuroscience, 6, 2125, 10.1016/0306-4522(81)90003-8

Weihmuller, 1992, Elevated NMDA receptors in parkinsonian striatum, NeuroReport, 3, 977, 10.1097/00001756-199211000-00007

Welch, 1996, Regulation of dopamine uptake in rat striatal tissue by NMDA receptors as measured using rotating disk electrode voltametry, Neurosci. Lett., 217, 184, 10.1016/0304-3940(96)13046-9

Werling, 1994, Increased activation of L-type voltage dependent calcium channels is associated with glycine enhancement of N-methyl-D-aspartate-stimulated dopamine release in global cerebral ischemia/reperfusion, J. Neurochem., 63, 215, 10.1046/j.1471-4159.1994.63010215.x

Westerink, 1989, Effect of ouabain applied by intrastriatal microdialysis on the in vivo release of dopamine, acetylcholine, and aminoacids in the brain of conscious rats, J. Neurochem., 52, 705, 10.1111/j.1471-4159.1989.tb02512.x

Wheeler, 1993, A model of the sodium dependence of dopamine uptake in rat striatal synaptosomes, Neurochem. Res., 18, 927, 10.1007/BF00998279

Wieczorek, 1994, A quantitative comparison on the effects of benztropine, cocaine and nomifensine on electrically evoked dopamine overflow and rate of Te-uptake in the caudate putamen and nucleus accumbens in the rat brain slice, Brain Res., 657, 42, 10.1016/0006-8993(94)90951-2

Wiener, 1989, Chronic L-deprenyl-induced up-regulation of the dopamine uptake carrier, Eur. J. Pharmacol., 163, 191, 10.1016/0014-2999(89)90418-4

Wightman, 1988, Real time characterization of dopamine overflow and uptake in the rat striatum, Neuroscience, 25, 513, 10.1016/0306-4522(88)90255-2

Wightman, 1990, Control of dopamine extracellular concentration in rat striatum by impulse flow and uptake, Brain Res. Rev., 15, 135, 10.1016/0165-0173(90)90015-G

Wolf, 1987, Dopamine autoreceptors, 45

Woodward, 1990, Ethanol inhibition of NMDA-stimulated endogenous dopamine release from rat striatal slices: reversal by glycine, J. Neurochem., 54, 712, 10.1111/j.1471-4159.1990.tb01931.x

Wullner, 1994, Glutamate receptors in striatum and substantia nigra: effects of medial forebrain bundle lesions, Brain Res., 645, 98, 10.1016/0006-8993(94)91642-X

Yadid, 1994, Endogenous serotonin stimulates striatal dopamine release in conscious rats, J. Pharm. Exp. Therap., 270, 1158

Yi, 1991, Effect of cocaine and 5HT3 receptor antagonists on 5HT-induced [3H]dopamine release from rat striatal synaptosomes, Eur. J. Pharm., 199, 185, 10.1016/0014-2999(91)90456-Z

Zaczek, 1990, Intrasynaptosomal sequestration of [3H]amphetamine and [3H]methylenedioxyamphetamine: characterization suggests the presence of a factor responsible for maintaining sequestration, J. Neurochem., 54, 195, 10.1111/j.1471-4159.1990.tb13301.x

Zaczek, 1991, Interactions of [3H]amphetamine with rat brain synaptosomes. II Active transport, J. Pharm. Exp. Therap., 257, 830

Zahniser, 1998, Voltage-dependency of the dopamine transporter in rat brain, Adv. Pharmac., 42, 195, 10.1016/S1054-3589(08)60726-7

Zahniser, 1999, In vivo dopamine clearance rate in rat striatum: regulation by extracellular dopamine concentration and dopamine transporter inhibitors, J. Pharm. Exp. Therap., 289, 266

Ziance, 1972, Characteristic of amphetamine induced release of norepinephrine from rat cerbral cortex in vitro, J. Pharm. Exp. Therap., 182, 284

Ziance, 1972, A comparison of the effects of fenfluramine and amphetamine on uptake, release and catabolism of norepinephrine in rat brain, J. Pharm. Exp. Therap., 180, 118

Zigmond, 1988, Animal models of parkinsonism using selective neurotoxins: clinical and basic implications

Zigmond, 1990, Compensatory changes after lesions of central dopaminergic neurons: some clinical and basis implications, Trends Neurosci., 13, 290, 10.1016/0166-2236(90)90112-N

Zhang, 1988, Increased dopamine release from striata of rats after unilateral nigrostriatal bundle damage, Brain Res., 461, 335, 10.1016/0006-8993(88)90264-8

Zoli, 1998, The emergence of the volume transmission concept, Brain Res. Rev., 26, 136, 10.1016/S0165-0173(97)00048-9